Search for: "Kelley v. Eli Lilly and Company" Results 1 - 6 of 6
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
8 Apr 2014, 8:02 am
Biotechnology Patents Under Attack: From Prometheus to Myriad, the Supreme Court's Narrowing View of Patent Eligible Subject Matter Panel: Jim Kelley, Senior Director-Assistant General Patent Counsel, Eli Lilly and Co; Paul Berghoff (Partner, McDonnell Boehnen Hulbert & Berghoff), Prof. [read post]
24 Feb 2011, 1:49 pm by Bexis
The complicated medical terminology necessary to explain the risk/benefit profile of prescription drugs/devices is difficult for ordinary patients to understand.Practical difficulties often preclude drug/device companies from direct communication with patients.But plaintiffs don’t make direct-to-patient warning claims only against drug/device companies. [read post]